AI start-up Paige has launched AI product OmniScreen, which can examine over 505 genes and identify 1,228 molecular biomarkers from pathology slides. CEO and CTO, Razik Yousfi, said the technology is faster and more cost-effective than other methods at detecting gene variations and could reduce costs associated with gene analysis.
Why True Healthcare Interoperability Needs AI
Consensus Cloud Solutions’ Johnny Hecker suggests that achieving interoperability in healthcare should involve artificial intelligence (AI) to lower costs for smaller organizations. Rather than implementing
